Total Payments
$7,974
2024 Payments
$203.92
Companies
36
Transactions
363
Medicare Patients
7,623
Medicare Billing
$602,196
Payment Breakdown by Category
Food & Beverage$6,815 (85.5%)
Travel$1,115 (14.0%)
Education$44.32 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,815 | 353 | 85.5% |
| Travel and Lodging | $1,115 | 4 | 14.0% |
| Education | $44.32 | 6 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Kowa Research Institute, Inc. | $1,445 | 10 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,071 | 54 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $866.98 | 48 | $0 (2024) |
| Abbott Laboratories | $433.04 | 7 | $0 (2022) |
| Amgen Inc. | $408.62 | 21 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $390.96 | 22 | $0 (2023) |
| Merck Sharp & Dohme LLC | $362.49 | 18 | $0 (2023) |
| Amarin Pharma Inc. | $331.65 | 27 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $318.82 | 22 | $0 (2023) |
| PFIZER INC. | $256.77 | 33 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $203.92 | 9 | Amgen Inc. ($78.09) |
| 2023 | $633.46 | 22 | Medtronic, Inc. ($124.66) |
| 2022 | $866.64 | 42 | Boehringer Ingelheim Pharmaceuticals, Inc. ($178.39) |
| 2021 | $1,213 | 57 | Boehringer Ingelheim Pharmaceuticals, Inc. ($260.16) |
| 2020 | $696.82 | 42 | Amarin Pharma Inc. ($159.36) |
| 2019 | $783.36 | 51 | Boehringer Ingelheim Pharmaceuticals, Inc. ($159.66) |
| 2018 | $787.59 | 51 | SANOFI-AVENTIS U.S. LLC ($138.93) |
| 2017 | $2,790 | 89 | Kowa Research Institute, Inc. ($1,445) |
All Payment Transactions
363 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/19/2024 | Edwards Lifesciences Corporation | SAPIEN 3 Ultra RESILIA (Device) | Food and Beverage | In-kind items and services | $23.39 | General |
| Category: Transcatheter Heart Valves | ||||||
| 06/17/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $29.70 | General |
| Category: Cardiology | ||||||
| 05/23/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/09/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $25.66 | General |
| Category: Cardiology | ||||||
| 04/29/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/23/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $31.55 | General |
| Category: Cardiology | ||||||
| 03/12/2024 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/28/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: Cardiology | ||||||
| 02/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: DIABETES | ||||||
| 11/06/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $26.57 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/10/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $31.38 | General |
| Category: Cardiology | ||||||
| 08/29/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $25.52 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/08/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: Cardiology | ||||||
| 07/18/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $22.05 | General |
| Category: Cardiovascular | ||||||
| 07/06/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/17/2023 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/10/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $27.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/25/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: DIABETES | ||||||
| 04/22/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $55.69 | General |
| Category: General - Embolics_PI | ||||||
| 04/17/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $24.27 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/04/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/23/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $24.48 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/22/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.44 | General |
| Category: DIABETES | ||||||
| 03/15/2023 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/23/2023 | Medtronic, Inc. | MICRA (Device) | Food and Beverage | In-kind items and services | $124.66 | General |
| Category: Pacemakers | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,539 | 3,136 | $350,120 | $126,501 |
| 2022 | 17 | 1,961 | 4,193 | $444,221 | $163,857 |
| 2021 | 17 | 1,920 | 4,466 | $441,835 | $164,707 |
| 2020 | 23 | 2,203 | 5,145 | $448,410 | $147,131 |
Total Patients
7,623
Total Services
16,940
Medicare Billing
$602,196
Procedure Codes
73
All Medicare Procedures & Services
73 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 417 | 733 | $164,192 | $67,309 | 41.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 76 | 97 | $29,100 | $13,456 | 46.2% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 86 | 506 | $22,770 | $9,087 | 39.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 443 | 638 | $47,850 | $6,208 | 13.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 101 | 101 | $13,433 | $5,427 | 40.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 41 | 41 | $14,063 | $4,978 | 35.4% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 82 | 185 | $10,360 | $3,435 | 33.2% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 42 | 52 | $6,396 | $3,246 | 50.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 44 | 48 | $7,296 | $3,090 | 42.4% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 59 | 137 | $9,590 | $2,989 | 31.2% |
| 85610 | Blood test, clotting time | Office | 2023 | 44 | 461 | $6,915 | $1,936 | 28.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 12 | 12 | $5,124 | $1,735 | 33.9% |
| 93283 | Programming of dual lead implantable defibrillator system | Office | 2023 | 13 | 20 | $3,420 | $1,538 | 45.0% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 23 | 49 | $6,811 | $1,178 | 17.3% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2023 | 28 | 28 | $1,680 | $581.31 | 34.6% |
| 93246 | Heart rhythm recording of continous external ekg over 8-15 days | Office | 2023 | 28 | 28 | $1,120 | $306.72 | 27.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 517 | 892 | $199,808 | $83,977 | 42.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 95 | 120 | $36,000 | $16,864 | 46.8% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 121 | 779 | $35,055 | $13,857 | 39.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 560 | 818 | $61,350 | $8,072 | 13.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 118 | 120 | $15,960 | $6,850 | 42.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 81 | 93 | $14,136 | $6,504 | 46.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 49 | 49 | $16,807 | $5,659 | 33.7% |
| 93280 | Programming of dual lead pacemaker system | Office | 2022 | 47 | 62 | $7,626 | $4,131 | 54.2% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2022 | 94 | 208 | $11,648 | $3,834 | 32.9% |
About Dr. John Hunter, M.D
Dr. John Hunter, M.D is a Cardiovascular Disease healthcare provider based in Santa Rosa, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1124062500.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Hunter, M.D has received a total of $7,974 in payments from pharmaceutical and medical device companies, with $203.92 received in 2024. These payments were reported across 363 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($6,815).
As a Medicare-enrolled provider, Hunter has provided services to 7,623 Medicare beneficiaries, totaling 16,940 services with total Medicare billing of $602,196. Data is available for 4 years (2020–2023), covering 73 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Santa Rosa, CA
- Active Since 06/15/2006
- Last Updated 11/14/2025
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1124062500
Products in Payments
- JARDIANCE (Drug) $822.14
- MULTAQ (Drug) $507.21
- ELIQUIS (Drug) $369.08
- VERQUVO (Drug) $362.49
- PRALUENT (Drug) $359.77
- Vascepa (Drug) $331.65
- XARELTO (Drug) $318.82
- ENTRESTO (Drug) $289.94
- Repatha (Biological) $256.88
- Carnation Ambulatory Monitor (Device) $249.40
- PRADAXA (Drug) $248.37
- Mitra Clip system (Device) $245.00
- BRILINTA (Drug) $230.17
- NORTHERA (Drug) $185.08
- Corlanor (Drug) $151.74
- MICRA (Device) $124.66
- MitraClip System (Device) $123.76
- PRALUENT ALIROCUMAB INJECTION (Biological) $115.48
- FARXIGA (Drug) $103.26
- OPSUMIT MACITENTAN (Drug) $102.46
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Santa Rosa
Dr. Vishal Patel, M.d, M.D
Cardiovascular Disease — Payments: $67,052
Cardiovascular Disease $67,052
Dr. Sanjay Dhar, Md, MD
Cardiovascular Disease — Payments: $22,684
Cardiovascular Disease $22,684
Masis Babajanian, M.d, M.D
Cardiovascular Disease — Payments: $14,999
Cardiovascular Disease $14,999
Dr. Stephen Halpern, Md, MD
Cardiovascular Disease — Payments: $14,166
Cardiovascular Disease $14,166
Dr. Daniel Brenner, Md / Phd, MD / PHD
Cardiovascular Disease — Payments: $13,201
Cardiovascular Disease $13,201
Emily Conway, M.d, M.D
Cardiovascular Disease — Payments: $9,883
Cardiovascular Disease $9,883